Company Quick10K Filing
Axon Enterprise
10-K 2020-12-31 Filed 2021-02-26
10-Q 2020-09-30 Filed 2020-11-06
10-Q 2020-06-30 Filed 2020-08-07
10-Q 2020-03-31 Filed 2020-05-08
10-K 2019-12-31 Filed 2020-02-28
10-Q 2019-09-30 Filed 2019-11-08
10-Q 2019-06-30 Filed 2019-08-09
10-Q 2019-03-31 Filed 2019-05-10
10-K 2018-12-31 Filed 2019-02-27
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-03-01
10-Q 2017-09-30 Filed 2017-11-09
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-10
10-K 2016-12-31 Filed 2017-03-06
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-10
10-Q 2016-03-31 Filed 2016-05-10
10-K 2015-12-31 Filed 2016-03-07
10-Q 2015-09-30 Filed 2015-11-06
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-08
10-K 2014-12-31 Filed 2015-03-12
10-Q 2014-09-30 Filed 2014-11-05
10-Q 2014-06-30 Filed 2014-08-05
10-Q 2014-03-31 Filed 2014-05-06
10-K 2013-12-31 Filed 2014-03-10
10-Q 2013-09-30 Filed 2013-11-05
10-Q 2013-03-31 Filed 2013-05-07
10-K 2012-12-31 Filed 2013-03-08
10-Q 2012-09-30 Filed 2012-11-09
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-10
10-K 2011-12-31 Filed 2012-03-13
10-Q 2011-09-30 Filed 2011-11-09
10-Q 2011-06-30 Filed 2011-08-08
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-14
10-Q 2010-09-30 Filed 2010-11-08
10-Q 2010-06-30 Filed 2010-08-06
10-Q 2010-03-31 Filed 2010-05-10
10-K 2009-12-31 Filed 2010-03-15
8-K 2020-11-05
8-K 2020-09-10
8-K 2020-08-06
8-K 2020-06-16
8-K 2020-06-12
8-K 2020-05-29
8-K 2020-05-07
8-K 2020-02-27
8-K 2020-01-04
8-K 2020-01-03
8-K 2019-11-07
8-K 2019-10-28
8-K 2019-10-10
8-K 2019-08-23
8-K 2019-08-08
8-K 2019-06-13
8-K 2019-05-31
8-K 2019-05-09
8-K 2019-02-26
8-K 2019-02-12
8-K 2018-12-31
8-K 2018-12-19
8-K 2018-12-19
8-K 2018-12-13
8-K 2018-11-06
8-K 2018-10-07
8-K 2018-09-14
8-K 2018-08-20
8-K 2018-08-07
8-K 2018-06-21
8-K 2018-05-24
8-K 2018-05-16
8-K 2018-05-08
8-K 2018-04-06
8-K 2018-02-27
8-K 2018-02-27

Axon Enterprise Financials

AAXN Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash28252124182638393248637860749047404660533751414228437595310327351225221204
Accounts Receivable1013121415151817172022212327312126242830303339444551568894117131149135149
Inventory16151111101011121312111315161823241916202226354961534543443934384141
PP&E32302726242351212019501818185117182058222223622630316831353678414043
Assets12611710510898103116117113128148165149164185196212213230237229252278300316328338393642682720739746792
Accounts Payable555444656567568876798911161812912991510915
Long-Term Debt0
Liabilities212323212226292933364041394656565864738494111127142153162171194194222252259257285
Stockholders' Equity105948287757687888092108124110118129140154149157153134141151157163166167199449460467481489508
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue21242126292932303435403637444745475056565972827980909510199105115116112131
Cost of Revenue9111410111121213141415161915161919192125323134403237363949474751
Gross Profit1213715191719182122262223292730313137373747504946506364636665696680
R&D32222222223454456777771012131416151922232325
SG&A99109810121113131214151214151518222524283131323640363940434348
Tax-10-133212221125-0335342731102-12801-02
Net Income-21-646443455348576253446520-213862616
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating5341010358119421713-219167312-4-7-672418-217-141122
Cash Investing40-1-0211-13-1-10-12-2-3-17-10-6-3-451-510-88101-81-111-14-38
Cash Financing-12-60-16-46-3-146811-19-126-80-10-251-1-21-0-2-3227-1-1-1-1